Covered recipient · General Payments record
LINDA B FAUST
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$579.68
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $282.34 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $73.92 | 4 |
| Novo Nordisk AS | $47.75 | 3 |
| Lilly USA, LLC | $35.34 | 2 |
| Acerta Pharma LLC | $34.81 | 2 |
| Edwards Lifesciences Corporation | $27.69 | 1 |
| GlaxoSmithKline, LLC. | $17.95 | 1 |
| Exact Sciences Corporation | $16.44 | 1 |
| Lucid Diagnostics Inc. | $15.04 | 1 |
| Amgen Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.12 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107093036 | CMS |
| ABBVIE INC. | $17.71 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107093038 | CMS |
| ABBVIE INC. | $21.67 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107093040 | CMS |
| ABBVIE INC. | $20.42 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107093042 | CMS |
| Amgen Inc. | $13.40 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117551811 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.66 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104631528 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.15 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105542329 | CMS |
| Edwards Lifesciences Corporation | $27.69 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138855572 | CMS |
| Exact Sciences Corporation | $16.44 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114427665 | CMS |
| GlaxoSmithKline, LLC. | $17.95 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116352022 | CMS |
| Lilly USA, LLC | $21.22 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135815348 | CMS |
| Lilly USA, LLC | $14.12 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135815350 | CMS |
| Lucid Diagnostics Inc. | $15.04 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152302975 | CMS |
| Novo Nordisk Inc | $15.00 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100234546 | CMS |
| Novo Nordisk Inc | $16.50 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100458154 | CMS |
| Novo Nordisk Inc | $16.25 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100469690 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.